Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
HURA	TUHURA BIOSCIENCES INC	$2.46	-6.11%	-12.46%	-40.00%	24.24%	-50.10%	-62.41%	-99.31%	-99.87%	-99.99%	$13.13	$1.80	81.26%	36.67%	0.77	105,000	34.62%
NVCT	NUVECTIS PHARMA INC	$8.41	-4.76%	-4.97%	-0.24%	0.72%	78.94%	23.13%	-31.01%	N/A	N/A	$11.80	$4.44	28.73%	89.41%	0.31	122,000	83.46%
GLMD	GALMED PHARMACEUTICALS LTD	$1.60	-0.62%	5.96%	24.03%	-4.76%	-46.13%	-62.96%	-98.15%	-99.82%	-99.91%	$23.80	$1.15	93.28%	39.13%	0.79	301,000	72.00%
ENTA	ENANTA PHARMACEUTICALS INC	$7.50	1.21%	0.40%	43.40%	9.81%	24.38%	-44.15%	-81.11%	-85.01%	-82.64%	$17.24	$4.09	56.48%	83.37%	0.93	244,000	-12.23%
EDIT	EDITAS MEDICINE INC	$1.97	-9.63%	3.14%	31.33%	43.80%	36.81%	-64.12%	-80.30%	-93.19%	N/A	$6.05	$0.91	67.44%	116.48%	2.03	3,051,000	-4.80%
MLYS	MINERALYS THERAPEUTICS INC	$14.32	-4.02%	-11.17%	-5.73%	6.07%	20.34%	12.84%	N/A	N/A	N/A	$18.38	$8.24	22.09%	73.77%	1.01	589,000	-18.76%
PGEN	PRECIGEN INC	$1.52	0.00%	1.33%	12.59%	-12.64%	125.19%	-10.59%	24.59%	-66.15%	-96.63%	$2.17	$0.65	29.95%	133.49%	1.70	1,254,000	52.93%
AMLX	AMYLYX PHARMACEUTICALS INC	$5.52	0.00%	3.56%	22.94%	50.41%	33.98%	228.57%	-57.54%	N/A	N/A	$7.27	$1.58	24.07%	250.48%	1.18	890,000	-14.51%
TCRX	TSCAN THERAPEUTICS INC	$1.55	-3.73%	-13.89%	16.54%	-13.41%	-45.61%	-82.78%	-47.46%	N/A	N/A	$8.51	$1.02	81.79%	51.96%	0.70	195,000	-22.92%
IMMP	IMMUTEP LTD	$1.74	0.58%	-6.45%	-7.94%	-0.57%	-20.18%	-36.26%	-25.32%	61.11%	-71.32%	$2.80	$1.32	37.86%	31.82%	0.93	47,000	-80.17%
RNAZ	TRANSCODE THERAPEUTICS INC	$6.97	-3.26%	-2.38%	-28.31%	-66.45%	-96.65%	-99.36%	-100.00%	N/A	N/A	$1.11k	$6.15	99.37%	13.37%	1.31	40,300	7.47%
XENE	XENON PHARMACEUTICALS INC	$32.76	-0.12%	3.54%	10.68%	-6.88%	-18.20%	-13.88%	20.26%	183.15%	154.35%	$46.00	$26.74	28.78%	22.51%	0.83	612,000	-42.21%
TRDA	ENTRADA THERAPEUTICS INC	$7.59	-3.31%	-8.77%	-12.76%	-29.85%	-57.02%	-53.86%	-22.47%	N/A	N/A	$21.79	$7.10	65.17%	6.90%	1.06	118,000	53.25%
JAGX	JAGUAR HEALTH INC	$3.49	-8.88%	-14.04%	-47.12%	-68.91%	-85.60%	-96.24%	-99.99%	-100.00%	-100.00%	$110.75	$3.49	96.85%	0.00%	1.28	70,000	37.25%
LYRA	LYRA THERAPEUTICS INC	$11.34	-4.30%	-53.29%	140.25%	29.60%	24.21%	-26.86%	-95.37%	-98.38%	N/A	$37.50	$3.81	69.76%	197.64%	0.56	220,000	-40.54%
MAIA	MAIA BIOTECHNOLOGY INC	$1.72	-1.71%	-4.44%	-5.49%	8.86%	-14.00%	-54.62%	N/A	N/A	N/A	$4.24	$1.40	59.43%	22.86%	0.43	59,600	-61.55%
AKRO	AKERO THERAPEUTICS INC	$55.62	3.85%	2.47%	39.02%	23.99%	92.52%	125.91%	590.07%	123.46%	N/A	$58.40	$21.02	4.76%	164.61%	0.55	2,224,000	41.39%
IMNN	IMUNON INC	$1.43	-11.73%	-2.05%	78.75%	62.87%	69.23%	19.67%	-25.98%	-97.40%	-99.72%	$3.65	$0.37	60.82%	286.49%	0.90	1,576,000	6.92%
HUMA	HUMACYTE INC	$2.37	-1.66%	-8.49%	36.99%	-14.44%	-42.20%	-67.08%	-38.28%	N/A	N/A	$9.79	$1.15	75.79%	106.09%	1.42	2,722,000	-14.72%
CGON	CG ONCOLOGY INC	$25.86	-2.42%	-3.90%	6.95%	-0.35%	-10.08%	-25.71%	N/A	N/A	N/A	$40.47	$14.80	36.10%	74.73%	1.56	626,000	-10.57%
GANX	GAIN THERAPEUTICS INC	$1.73	-3.89%	-9.90%	-10.36%	-21.36%	6.13%	-8.47%	-46.77%	N/A	N/A	$3.19	$0.89	45.77%	94.38%	1.07	221,000	2.79%
IDYA	IDEAYA BIOSCIENCES INC	$22.18	-0.45%	2.07%	27.11%	16.98%	-11.95%	-43.03%	111.44%	147.82%	N/A	$44.42	$13.45	50.07%	64.91%	1.07	863,000	-38.00%
QTTB	Q32 BIO INC	$1.67	-1.76%	-12.11%	-4.02%	-9.24%	-54.86%	-91.51%	-95.22%	-99.39%	N/A	$53.79	$1.38	96.90%	21.01%	1.12	155,000	170.03%
OKUR	ONKURE THERAPEUTICS INC	$2.65	-7.02%	-7.99%	44.02%	-42.64%	-73.12%	55.88%	21.56%	N/A	N/A	$19.60	$1.25	86.48%	112.00%	0.74	165,000	315.62%
CRBU	CARIBOU BIOSCIENCES INC	$1.11	-4.31%	-11.90%	41.76%	12.58%	-41.88%	-42.49%	-78.24%	N/A	N/A	$3.00	$0.66	62.99%	68.18%	1.79	1,163,000	31.12%
QSI	QUANTUM-SI INC	$1.66	-7.26%	-4.60%	13.70%	45.61%	-3.49%	15.28%	-44.11%	N/A	N/A	$5.77	$0.61	71.23%	171.24%	1.89	8,176,000	-11.93%
ADTX	ADITXT INC	$1.38	-4.83%	-10.39%	-15.34%	-83.47%	-98.41%	-99.99%	-100.00%	N/A	N/A	$27.20k	$1.34	99.99%	2.99%	0.56	80,000	-9.09%
CMPX	COMPASS THERAPEUTICS INC	$2.41	0.00%	-3.60%	20.50%	-2.43%	65.07%	107.76%	19.90%	N/A	N/A	$4.08	$0.77	40.93%	215.03%	0.97	747,000	68.24%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$4.06	2.78%	-14.80%	-24.11%	-66.33%	-89.26%	-77.13%	-98.64%	N/A	N/A	$53.10	$3.40	92.35%	19.41%	0.87	62,000	-31.87%
ORIC	ORIC PHARMACEUTICALS INC	$9.63	-0.41%	3.33%	81.36%	25.06%	13.03%	25.39%	136.61%	-72.02%	N/A	$14.67	$3.90	34.36%	147.24%	1.09	714,000	-12.39%
GHRS	GH RESEARCH PLC	$12.76	-0.55%	2.08%	26.84%	17.28%	64.86%	0.87%	30.07%	N/A	N/A	$20.50	$6.00	37.76%	112.67%	0.95	147,000	-68.52%
CAPR	CAPRICOR THERAPEUTICS INC	$11.78	-15.49%	-17.22%	61.37%	-7.90%	-11.16%	122.68%	211.64%	150.64%	-77.30%	$23.40	$3.52	49.66%	234.66%	0.99	3,117,000	196.29%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$0.73	-6.41%	-10.98%	-12.47%	-29.81%	-72.03%	-51.33%	-33.64%	-93.20%	N/A	$4.28	$0.49	82.94%	50.52%	0.62	773,000	48.08%
SXTP	60 DEGREES PHARMACEUTICALS INC	$2.21	-3.07%	-24.32%	-7.53%	26.29%	-68.65%	-86.93%	N/A	N/A	N/A	$35.99	$1.41	93.86%	56.74%	-0.46	94,500	62.93%
LTRN	LANTERN PHARMA INC	$3.05	-5.57%	-8.13%	-25.79%	-18.45%	-11.47%	-43.93%	-36.72%	-79.22%	N/A	$6.12	$2.55	50.15%	19.61%	1.13	128,000	-34.69%
MGTX	MEIRAGTX HOLDINGS PLC	$6.63	0.61%	10.50%	28.74%	-19.64%	8.33%	43.82%	-9.92%	-51.78%	N/A	$8.75	$3.85	24.23%	72.21%	1.19	487,000	0.21%
ALT	ALTIMMUNE INC	$6.92	-3.22%	23.13%	20.14%	33.08%	-23.37%	4.69%	-25.03%	-9.90%	-98.64%	$11.16	$3.55	37.99%	94.76%	1.29	4,336,000	-34.76%
SION	SIONNA THERAPEUTICS INC	$16.38	-3.59%	-4.88%	27.72%	-4.21%	N/A	N/A	N/A	N/A	N/A	$25.19	$7.26	34.97%	125.78%	0.93	101,000	-3.81%
OCGN	OCUGEN INC	$1.13	-5.83%	6.60%	60.74%	108.49%	31.86%	-25.66%	-42.93%	318.52%	-99.73%	$1.98	$0.52	42.90%	119.42%	1.90	4,867,000	3.27%
AUTL	AUTOLUS THERAPEUTICS PLC	$2.12	-1.40%	-9.40%	66.93%	12.17%	-14.86%	-53.20%	-7.02%	-83.69%	N/A	$5.00	$1.11	57.60%	91.86%	1.01	1,897,000	-32.56%
ABSI	ABSCI CORP	$2.78	-2.11%	-8.25%	-6.08%	-4.14%	-24.76%	-36.38%	-12.03%	N/A	N/A	$6.33	$2.01	56.08%	38.31%	2.11	2,238,000	-19.03%
MBX	MBX BIOSCIENCES INC	$10.37	-3.26%	-8.80%	0.97%	20.16%	-45.25%	N/A	N/A	N/A	N/A	$27.50	$4.81	62.29%	115.73%	1.45	123,000	-12.77%
RPTX	REPARE THERAPEUTICS INC	$1.47	1.17%	-0.20%	2.59%	30.98%	-17.12%	-62.58%	-89.16%	-95.24%	N/A	$4.29	$0.89	65.80%	64.83%	1.17	37,200	-51.69%
BLTE	BELITE BIO INC	$59.55	-4.17%	-0.22%	-2.20%	-14.30%	-4.48%	18.86%	161.76%	N/A	N/A	$86.53	$43.70	31.18%	36.27%	0.16	21,000	-36.94%
GALT	GALECTIN THERAPEUTICS INC	$1.37	2.24%	3.79%	3.79%	-22.16%	-35.07%	-48.50%	3.01%	-52.60%	-56.78%	$3.17	$0.73	56.78%	88.71%	0.78	188,000	88.00%
CRIS	CURIS INC	$2.45	-11.55%	3.38%	15.57%	-13.73%	-31.37%	-71.18%	-88.55%	-90.28%	-99.25%	$8.48	$1.02	71.11%	140.20%	0.89	70,000	-26.32%
TIL	INSTIL BIO INC	$34.23	-8.73%	4.07%	168.68%	79.59%	55.80%	226.00%	-65.07%	N/A	N/A	$92.00	$9.62	62.79%	255.82%	1.75	221,000	-3.49%
URGN	UROGEN PHARMA LTD	$12.03	8.57%	63.23%	18.64%	10.37%	5.99%	-31.26%	83.38%	-54.77%	N/A	$19.01	$3.42	36.72%	251.75%	0.91	19,687,000	-6.61%
BCLI	BRAINSTORM CELL THERAPEUTICS INC	$1.10	-6.78%	-9.84%	-9.09%	-29.49%	-24.14%	-83.45%	-97.46%	-99.26%	-98.03%	$6.94	$0.72	84.15%	52.14%	0.73	262,000	11.49%
ZVSA	ZYVERSA THERAPEUTICS INC	$0.65	-10.56%	-0.46%	25.87%	-18.60%	-37.90%	-86.64%	-99.98%	N/A	N/A	$6.30	$0.47	89.65%	37.84%	0.23	380,000	-66.19%
MRNA	MODERNA INC	$26.67	-2.49%	-2.88%	4.63%	-22.24%	-36.24%	-81.64%	-77.23%	-59.94%	N/A	$139.92	$23.15	80.94%	15.21%	1.20	7,146,000	-13.80%
INO	INOVIO PHARMACEUTICALS INC	$2.00	-3.85%	-11.89%	4.17%	3.63%	-13.79%	-78.84%	-88.58%	-98.82%	-98.04%	$12.33	$1.42	83.78%	40.85%	1.43	617,000	-15.83%
SAGE	SAGE THERAPEUTICS INC	$6.70	1.52%	-2.19%	1.36%	-14.65%	24.42%	-41.74%	-79.06%	-82.04%	-91.41%	$13.47	$4.62	50.26%	45.02%	1.11	647,000	53.68%
AARD	AARDVARK THERAPEUTICS INC	$10.74	-2.89%	-9.06%	5.92%	2.48%	N/A	N/A	N/A	N/A	N/A	$19.58	$4.88	45.15%	120.08%	1.23	14,800	3.50%
PRTG	PORTAGE BIOTECH INC	$5.99	-5.07%	-28.78%	-24.70%	48.27%	99.67%	17.82%	-97.45%	N/A	N/A	$23.01	$2.10	73.97%	185.51%	1.09	17,700	-61.85%
GLSI	GREENWICH LIFESCIENCES INC	$9.20	-2.85%	-4.76%	-5.06%	-21.90%	-31.90%	-38.05%	19.33%	N/A	N/A	$18.75	$8.06	50.93%	14.14%	0.55	23,000	164.37%
KRRO	KORRO BIO INC	$13.54	-3.15%	-7.20%	-12.93%	-45.09%	-71.12%	-68.14%	-77.05%	-98.65%	N/A	$98.00	$10.29	86.18%	31.58%	1.15	66,500	-8.90%
EYPT	EYEPOINT PHARMACEUTICALS INC	$9.03	1.92%	1.01%	52.79%	32.21%	21.05%	-2.80%	19.92%	7.76%	-75.98%	$13.99	$3.91	35.43%	130.95%	1.11	822,000	3.92%
CVM	CEL SCI CORP	$2.25	-5.06%	-5.46%	-71.03%	-75.17%	-89.13%	-94.19%	-97.90%	-99.42%	-99.60%	$66.60	$1.98	96.62%	13.64%	0.90	152,000	31.03%
ATOS	ATOSSA THERAPEUTICS INC	$0.83	-3.71%	-7.67%	-6.63%	21.31%	-25.80%	-32.44%	-21.60%	-72.84%	-99.64%	$1.66	$0.55	49.94%	50.27%	1.30	518,000	-27.96%
PMVP	PMV PHARMACEUTICALS INC	$1.08	-0.92%	11.34%	26.76%	-12.90%	-31.65%	-37.93%	-88.30%	N/A	N/A	$1.82	$0.81	40.66%	33.33%	1.20	177,000	-31.66%
MTSR	METSERA INC	$29.38	-15.04%	6.88%	12.57%	21.10%	N/A	N/A	N/A	N/A	N/A	$37.99	$12.30	22.66%	138.86%	1.81	808,000	67.98%
RAPP	RAPPORT THERAPEUTICS INC	$11.19	0.45%	-11.61%	12.01%	11.68%	-40.38%	-51.45%	N/A	N/A	N/A	$29.74	$6.43	62.37%	74.03%	1.27	101,000	-46.84%
VIR	VIR BIOTECHNOLOGY INC	$5.22	0.00%	-4.22%	11.06%	-25.43%	-29.93%	-49.61%	-76.37%	-85.35%	N/A	$14.45	$4.32	63.88%	20.83%	1.18	893,000	12.05%
VERU	VERU INC	$0.61	-6.43%	-1.13%	18.41%	35.48%	-15.49%	-27.18%	-95.16%	-82.84%	-75.06%	$1.42	$0.45	56.97%	35.78%	1.03	1,781,000	-28.27%
DOMH	DOMINARI HOLDINGS INC	$4.86	-7.60%	-10.00%	-15.03%	-7.43%	215.58%	125.21%	-5.63%	-62.87%	-99.41%	$13.58	$0.83	64.21%	488.38%	1.09	111,000	25.42%
CNSP	CNS PHARMACEUTICALS INC	$0.81	-9.33%	-22.40%	-40.66%	-70.22%	-84.31%	-99.55%	-100.00%	-100.00%	N/A	$200.00	$0.77	99.60%	4.53%	0.72	337,000	19.93%
PDSB	PDS BIOTECHNOLOGY CORP	$1.75	-2.23%	3.55%	37.80%	38.89%	-4.89%	-41.67%	-42.62%	34.62%	N/A	$4.42	$0.85	60.41%	105.64%	1.90	332,000	-53.70%
ELTX	ELICIO THERAPEUTICS INC	$7.60	-5.24%	-2.94%	33.10%	-3.80%	49.90%	-10.48%	-56.82%	N/A	N/A	$9.99	$3.34	23.92%	127.41%	1.05	34,300	35.04%
ACRV	ACRIVON THERAPEUTICS INC	$1.20	-5.51%	-11.11%	6.19%	-76.33%	-83.00%	-84.46%	N/A	N/A	N/A	$10.16	$1.05	88.19%	14.29%	1.47	308,000	2.67%
SCPH	SCPHARMACEUTICALS INC	$3.95	-1.25%	-5.95%	70.26%	32.11%	23.82%	-2.71%	-12.22%	-44.52%	N/A	$5.65	$1.94	30.09%	103.61%	0.98	211,000	-3.21%
PRTA	PROTHENA CORP PUBLIC LTD CO	$5.08	0.20%	-6.10%	-33.07%	-63.89%	-60.28%	-76.23%	-77.65%	-46.86%	-89.27%	$25.42	$4.32	80.02%	17.59%	1.42	806,000	23.62%
INAB	IN8BIO INC	$2.26	-5.04%	-45.80%	-52.92%	-66.71%	-73.55%	-95.52%	-96.43%	N/A	N/A	$34.50	$2.22	93.45%	1.80%	0.95	173,000	-29.10%
SLNO	SOLENO THERAPEUTICS INC	$79.15	-1.31%	4.82%	6.33%	61.43%	69.45%	75.81%	3,000.27%	169.22%	-70.52%	$81.54	$36.93	2.93%	114.32%	0.54	621,000	-36.57%
COYA	COYA THERAPEUTICS INC	$5.63	4.84%	-4.25%	-2.26%	-13.12%	-4.41%	-27.63%	N/A	N/A	N/A	$10.24	$4.65	45.02%	21.08%	0.90	67,000	-62.98%
MRUS	MERUS NV	$54.61	-1.41%	-2.85%	33.46%	14.63%	27.50%	-5.27%	177.49%	260.46%	N/A	$62.98	$33.19	13.29%	64.54%	0.95	712,000	-52.41%
ELDN	ELEDON PHARMACEUTICALS INC	$2.87	-4.33%	-6.82%	-1.03%	-20.28%	-34.47%	-2.38%	-17.88%	-69.36%	-99.88%	$5.54	$2.30	48.19%	24.78%	0.71	195,000	62.50%
EWTX	EDGEWISE THERAPEUTICS INC	$15.29	-0.84%	0.33%	2.69%	-39.52%	-44.64%	-14.63%	154.83%	N/A	N/A	$38.12	$10.60	59.89%	44.25%	1.39	878,000	-13.41%
FBRX	FORTE BIOSCIENCES INC	$12.09	-3.63%	6.76%	77.72%	101.42%	-47.80%	-13.68%	-60.38%	-97.44%	N/A	$28.68	$4.11	57.86%	194.04%	0.80	34,400	616.67%
NUVB	NUVATION BIO INC	$1.73	-4.42%	-30.24%	-21.00%	-21.72%	-33.72%	-42.14%	-49.12%	N/A	N/A	$3.97	$1.54	56.42%	12.34%	1.16	8,955,000	-52.13%
GLPG	GALAPAGOS NV	$28.76	-0.38%	3.71%	7.15%	10.66%	7.23%	11.82%	-46.66%	-85.61%	-43.35%	$31.23	$22.36	7.89%	28.62%	0.62	322,000	120.55%
TRML	TOURMALINE BIO INC	$19.68	-1.11%	2.13%	26.64%	15.49%	-9.77%	18.55%	-74.38%	N/A	N/A	$29.79	$11.56	33.93%	70.24%	1.23	152,000	-47.95%
IGMS	IGM BIOSCIENCES INC	$1.21	0.00%	-8.33%	5.22%	-6.20%	-83.12%	-84.76%	-91.21%	-98.15%	N/A	$22.50	$0.92	94.62%	31.52%	1.62	148,000	30.97%
ALLO	ALLOGENE THERAPEUTICS INC	$1.34	-4.29%	-5.63%	18.58%	-29.10%	-29.10%	-47.24%	-84.86%	-96.81%	N/A	$3.78	$0.86	64.55%	55.45%	1.39	2,450,000	7.31%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$0.70	-1.82%	-8.84%	-24.38%	-33.87%	-64.05%	-73.35%	-74.04%	N/A	N/A	$3.09	$0.66	77.31%	6.21%	1.52	161,000	-21.46%
OABI	OMNIAB INC	$1.78	4.09%	18.67%	27.14%	-44.55%	-53.03%	-57.82%	-82.36%	-82.82%	N/A	$4.96	$1.22	64.11%	45.90%	0.54	870,000	3.57%
RNXT	RENOVORX INC	$1.30	-4.41%	-6.47%	26.21%	27.45%	1.56%	23.81%	-35.32%	N/A	N/A	$1.69	$0.75	23.08%	73.33%	0.87	139,000	88.86%
MBRX	MOLECULIN BIOTECH INC	$0.64	-3.89%	-4.18%	-40.00%	-44.66%	-72.33%	-85.24%	-96.81%	-99.36%	N/A	$4.71	$0.40	86.36%	61.31%	0.85	307,000	-38.23%
APGE	APOGEE THERAPEUTICS INC	$44.48	6.26%	8.54%	11.93%	16.04%	-0.04%	3.15%	N/A	N/A	N/A	$63.50	$26.20	29.95%	69.77%	1.25	1,255,000	14.09%
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$44.21	0.43%	-5.70%	14.71%	16.90%	-13.89%	3.51%	750.19%	N/A	N/A	$58.26	$31.42	24.12%	40.71%	0.58	316,000	-61.46%
IPA	IMMUNOPRECISE ANTIBODIES LTD	$0.70	-3.84%	4.46%	41.25%	73.33%	74.19%	-33.14%	-82.79%	N/A	N/A	$1.08	$0.27	35.00%	160.00%	0.78	3,690,000	-94.64%
RLMD	RELMADA THERAPEUTICS INC	$0.70	-0.85%	-16.17%	79.49%	157.35%	90.74%	-76.74%	-95.86%	-98.55%	N/A	$4.47	$0.24	84.34%	191.67%	0.68	201,000	-72.24%
VTYX	VENTYX BIOSCIENCES INC	$2.56	2.81%	4.07%	113.33%	84.17%	12.28%	-10.80%	-79.63%	N/A	N/A	$3.39	$0.78	24.48%	226.95%	1.38	844,000	-46.34%
VTGN	VISTAGEN THERAPEUTICS INC	$2.21	-4.54%	-6.36%	-6.75%	-18.75%	-9.05%	-37.22%	-92.08%	-85.59%	N/A	$4.21	$1.90	47.51%	16.32%	1.65	160,000	50.94%
QNCX	QUINCE THERAPEUTICS INC	$1.43	19.17%	22.22%	50.53%	1.42%	-29.56%	104.87%	-47.23%	-96.96%	N/A	$2.45	$0.51	41.63%	179.30%	0.69	656,000	-54.03%
AVTX	AVALO THERAPEUTICS INC	$4.84	-0.82%	18.05%	31.52%	-34.77%	-47.56%	-58.38%	-99.62%	-99.93%	N/A	$16.00	$3.39	69.75%	42.77%	0.85	44,200	-5.96%
CRGX	CARGO THERAPEUTICS INC	$4.39	-2.01%	-7.58%	10.58%	6.30%	-68.05%	-74.45%	N/A	N/A	N/A	$25.45	$3.00	82.75%	46.33%	1.04	396,000	-0.25%
DBVT	DBV TECHNOLOGIES SA	$9.10	-6.09%	-0.33%	-17.20%	74.66%	154.90%	76.70%	-60.78%	-83.42%	-96.66%	$12.78	$2.20	28.79%	312.89%	0.53	13,600	-67.39%
HOWL	WEREWOLF THERAPEUTICS INC	$1.22	-5.43%	-14.08%	19.61%	0.83%	-26.06%	-62.46%	-74.90%	N/A	N/A	$4.18	$0.60	70.81%	105.04%	1.40	307,000	-40.62%
MDCX	MEDICUS PHARMA LTD	$2.60	-6.81%	-5.80%	-52.73%	-24.42%	-5.45%	N/A	N/A	N/A	N/A	$8.94	$1.80	70.92%	44.44%	0.63	133,000	-26.92%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #1 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 62, which is 38 points higher than the biotech industry average of 24.

AUPH passed 20 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 52.9% over the past year, overperforming other biotech stocks by 129 percentage points.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 67, which is 43 points higher than the biotech industry average of 24.

EXEL passed 22 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 89.39% over the past year, overperforming other biotech stocks by 166 percentage points.

Exelixis has an average 1 year price target of $39.94, a downside of -3.97% from Exelixis's current stock price of $41.59.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Exelixis, 31.25% have issued a Strong Buy rating, 18.75% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 73, which is 49 points higher than the biotech industry average of 24.

CPRX passed 24 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 53.49% over the past year, overperforming other biotech stocks by 130 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $32.50, an upside of 38.12% from Catalyst Pharmaceuticals's current stock price of $23.53.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Catalyst Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.58%, which is 5 percentage points higher than the biotech industry average of 1.63%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.02%, which is the same as the biotech industry average of 1.63%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.87%, which is the same as the biotech industry average of 1.63%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.4% in the last day, and down -1.07% over the last week. Biorestorative Therapies was the among the top losers in the biotechnology industry, dropping -16% yesterday.

BioRestorative Therapies shares are trading lower. The company announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 0.9% in the past year. It has overperformed other stocks in the biotech industry by 77 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 10.79% in the past year. It has overperformed other stocks in the biotech industry by 87 percentage points.

3. United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -1.47% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

53.31% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 99.94% over the next year.

2.39% of biotech stocks have a Zen Rating of A (Strong Buy), 4.56% of biotech stocks are rated B (Buy), 35.57% are rated C (Hold), 36.66% are rated D (Sell), and 20.82% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -108.97x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

2. Exelixis (NASDAQ:EXEL)

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

2. Exelixis (NASDAQ:EXEL)

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.